nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000676	0.000676	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000675	0.000675	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000673	0.000673	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000669	0.000669	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000669	0.000669	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000668	0.000668	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000665	0.000665	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000664	0.000664	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000661	0.000661	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00066	0.00066	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000659	0.000659	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000659	0.000659	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000656	0.000656	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000655	0.000655	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000654	0.000654	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000653	0.000653	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000646	0.000646	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000645	0.000645	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000643	0.000643	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000642	0.000642	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00064	0.00064	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000639	0.000639	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000639	0.000639	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00063	0.00063	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000628	0.000628	CbGpPWpGaD
Ergotamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000628	0.000628	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000616	0.000616	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000615	0.000615	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000615	0.000615	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000615	0.000615	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000614	0.000614	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00061	0.00061	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000609	0.000609	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000608	0.000608	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000608	0.000608	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000603	0.000603	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000601	0.000601	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000599	0.000599	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000599	0.000599	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000598	0.000598	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000595	0.000595	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000587	0.000587	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000587	0.000587	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000586	0.000586	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000584	0.000584	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000572	0.000572	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000569	0.000569	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000567	0.000567	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000565	0.000565	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000559	0.000559	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000559	0.000559	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000558	0.000558	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000557	0.000557	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000556	0.000556	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000554	0.000554	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000551	0.000551	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000551	0.000551	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000548	0.000548	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000547	0.000547	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000544	0.000544	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000537	0.000537	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000536	0.000536	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000535	0.000535	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000534	0.000534	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000532	0.000532	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000532	0.000532	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000529	0.000529	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000526	0.000526	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000518	0.000518	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000515	0.000515	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000513	0.000513	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000513	0.000513	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000512	0.000512	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000511	0.000511	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000509	0.000509	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000508	0.000508	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000507	0.000507	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000506	0.000506	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000505	0.000505	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000504	0.000504	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000496	0.000496	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000488	0.000488	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000487	0.000487	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000485	0.000485	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000471	0.000471	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00047	0.00047	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000469	0.000469	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000467	0.000467	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000465	0.000465	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000464	0.000464	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000464	0.000464	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000463	0.000463	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000463	0.000463	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000462	0.000462	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000461	0.000461	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000459	0.000459	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000456	0.000456	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000455	0.000455	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000454	0.000454	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000452	0.000452	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000451	0.000451	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00045	0.00045	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000447	0.000447	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000445	0.000445	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000442	0.000442	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000438	0.000438	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000428	0.000428	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000427	0.000427	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000427	0.000427	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000427	0.000427	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000426	0.000426	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000424	0.000424	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000422	0.000422	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000421	0.000421	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00042	0.00042	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00042	0.00042	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000418	0.000418	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000418	0.000418	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000415	0.000415	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000412	0.000412	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000409	0.000409	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000407	0.000407	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000398	0.000398	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000393	0.000393	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000393	0.000393	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000392	0.000392	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000389	0.000389	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000386	0.000386	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000386	0.000386	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000386	0.000386	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000383	0.000383	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000378	0.000378	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000378	0.000378	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000366	0.000366	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000359	0.000359	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000359	0.000359	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000358	0.000358	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000356	0.000356	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000355	0.000355	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000355	0.000355	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000353	0.000353	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000351	0.000351	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000349	0.000349	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000348	0.000348	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000347	0.000347	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000346	0.000346	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000345	0.000345	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000336	0.000336	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000335	0.000335	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000335	0.000335	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000335	0.000335	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00033	0.00033	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00033	0.00033	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00033	0.00033	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000328	0.000328	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000324	0.000324	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000321	0.000321	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00032	0.00032	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000319	0.000319	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000317	0.000317	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000316	0.000316	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000315	0.000315	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000306	0.000306	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000305	0.000305	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000304	0.000304	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000303	0.000303	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000299	0.000299	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000298	0.000298	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000297	0.000297	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000295	0.000295	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000293	0.000293	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000293	0.000293	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000291	0.000291	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000291	0.000291	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00029	0.00029	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000288	0.000288	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000286	0.000286	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000286	0.000286	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000285	0.000285	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00028	0.00028	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000276	0.000276	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000275	0.000275	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000275	0.000275	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000274	0.000274	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.000273	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000272	0.000272	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.00027	0.00027	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000269	0.000269	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000266	0.000266	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000265	0.000265	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000264	0.000264	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000257	0.000257	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000254	0.000254	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000253	0.000253	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000253	0.000253	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000252	0.000252	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00025	0.00025	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000249	0.000249	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000243	0.000243	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000233	0.000233	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000232	0.000232	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00023	0.00023	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000229	0.000229	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000227	0.000227	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000226	0.000226	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000225	0.000225	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000222	0.000222	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000221	0.000221	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000221	0.000221	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00022	0.00022	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000219	0.000219	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000211	0.000211	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000209	0.000209	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000209	0.000209	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000208	0.000208	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000194	0.000194	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000194	0.000194	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000194	0.000194	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000191	0.000191	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000187	0.000187	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000187	0.000187	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000187	0.000187	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000183	0.000183	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000179	0.000179	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000176	0.000176	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000175	0.000175	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000174	0.000174	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000172	0.000172	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000169	0.000169	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000169	0.000169	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000161	0.000161	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00016	0.00016	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000149	0.000149	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000149	0.000149	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000146	0.000146	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000144	0.000144	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000143	0.000143	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00014	0.00014	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000139	0.000139	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	0.000135	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000133	0.000133	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000133	0.000133	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000123	0.000123	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000121	0.000121	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000118	0.000118	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	0.000115	0.000115	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000115	0.000115	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00011	0.00011	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	8.84e-05	8.84e-05	CbGpPWpGaD
